Genmab A/S (DE:GE9)

XETRA:GE9

GE9

Genmab A/S

RESEARCH TOOLSreports

Compare Genmab A/S (GE9) vs. Competitors

14 Followers

Comparison Results

GE9

Genmab A/S

€242.60

€14.86B

126.08

47.18%

4 Buy

2 Hold

1 Sell

Moderate Buy

Genmab A/S

kr1779.24

kr111.05B

126.08

48.81%

4 Buy

2 Hold

1 Sell

Moderate Buy

GlaxoSmithKline

2167.00 p

£86.94B

12.93

70.67%

3 Buy

6 Hold

3 Sell

Hold

AstraZeneca

15276.00 p

£236.19B

28.13

52.03%

13 Buy

2 Hold

1 Sell

Strong Buy

Hikma Pharmaceuticals

1554.00 p

£2.86B

11.21

-28.11%

2 Buy

0 Hold

1 Sell

Moderate Buy

xxxxxxxxxxxxx

GE9 vs HIK

xxxxxxxxxxxxx

Performance Comparison

DE:GE9

Genmab A/S

240.50

74.80

45.14%

GB:0MGB

Genmab A/S

1,811.06

586.06

47.84%

GB:GSK

GlaxoSmithKline

2,176.00

932.53

74.99%

GB:AZN

AstraZeneca

15,230.00

5,393.44

54.83%

GB:HIK

Hikma Pharmaceuticals

1,322.00

-430.74

-24.58%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >